Texas Attorney General Files Lawsuit Against Johnson and Johnson Over Tylenol and Pregnancy Risks
Texas Attorney General Ken Paxton has filed a lawsuit against Johnson and Johnson, alleging that the pharmaceutical company did not adequately warn consumers about the risks of taking Tylenol during pregnancy. This legal action, the first of its kind by a state government, follows updated guidance from President Donald Trump and U.S. Secretary of Health and Human Services Robert F. Kennedy, Jr., cautioning pregnant women against using acetaminophen due to a potential link to autism. The controversy surrounding this issue has caused confusion among pregnant women seeking relief from fever and pain during pregnancy.
The connection between Tylenol and autism remains uncertain, with conflicting research findings. While some studies suggest a possible correlation between Tylenol use during pregnancy and autism in children, other studies have refuted these claims. Leading medical associations have criticized the generalized statements made by Kennedy and Trump, emphasizing the importance of treating dangerous conditions during pregnancy with acetaminophen to prevent severe health risks for both the pregnant individual and the fetus.
The issue of Tylenol use during pregnancy has been the subject of numerous personal injury lawsuits against Johnson and Johnson and its spin-off company, Kenvue. These cases have been consolidated into multi-district litigation, led by attorney Ashley Keller, who has been contracted by the attorney general's office to handle the lawsuit against Johnson and Johnson. Paxton, who is running for the GOP primary to challenge U.S. Sen. John Cornyn, aims to hold pharmaceutical companies accountable for potential harm to consumers.
Autism affects approximately one in 31 American children, with diagnoses increasing significantly over the past two decades. While researchers attribute this rise to improved screening and expanded diagnostic criteria, Kennedy has focused on investigating and eliminating potential causes of autism, including the use of acetaminophen during pregnancy. Despite conflicting research findings, Kennedy has taken steps to relabel Tylenol based on studies suggesting a slight association between acetaminophen use during pregnancy and autism.
Kenvue, the manufacturer of Tylenol, has disputed claims linking acetaminophen to autism, citing independent scientific evidence that does not support such a connection. Keller, the attorney leading the litigation against Johnson and Johnson, advocates for informing individuals about potential risks and uncertainties surrounding Tylenol use during pregnancy, allowing them to make informed decisions. The lawsuit filed by Paxton alleges that Johnson and Johnson ignored scientific evidence regarding acetaminophen and autism, specifically targeting the creation of Kenvue to shield the main company from liability.
The lawsuit brought by Paxton against Johnson and Johnson is based on state consumer protection laws, focusing on fraudulent transfer and deceptive trade practices. This legal action differs from individual personal injury claims and seeks damages under these specific statutes. Texas has a history of legal action against Johnson and Johnson, including settlements related to the opioid epidemic, medical devices, and deceptive marketing practices. The ongoing litigation underscores the importance of addressing potential risks associated with acetaminophen use during pregnancy and holding pharmaceutical companies accountable for consumer safety.